Holdings
Bvf Inc
As of Jun 30, 2026, Bvf Inc reported 36 positions worth US$2.98B. Largest: Revolution Medicines, Inc., Kymera Therapeutics, Inc. and Xoma Royalty Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Revolution Medicines, Inc. | 2.97M | US$555M | +108K | Jun 30, 2026 |
| Kymera Therapeutics, Inc. | 3.87M | US$444M | −1.63M | Jun 30, 2026 |
| Xoma Royalty Corporation | 7.59M | US$323M | +5M | Jun 30, 2026 |
| Nektar Therapeutics | 2.39M | US$167M | −169K | Jun 30, 2026 |
| Mirum Pharmaceuticals, Inc. | 1.06M | US$124M | −529K | Jun 30, 2026 |
| Xencor, Inc. | 7.13M | US$115M | no change | Jun 30, 2026 |
| Monte Rosa Therapeutics, Inc. | 4.46M | US$108M | no change | Jun 30, 2026 |
| Cullinan Therapeutics, Inc. | 5.75M | US$105M | no change | Jun 30, 2026 |
| Palvella Therapeutics, Inc. | 673K | US$103M | −288K | Jun 30, 2026 |
| Zymeworks Inc. | 3.65M | US$95.4M | −85,000 | Jun 30, 2026 |